MEDICAL COLLEGE OF WISCONSIN

700 new health professionals pledged commitment to patient care at Gulf Medical University's 26th White Coat Ceremony, joining 5,000 students from 102 nationalities. The event highlighted the integration of AI in healthcare education and the university's partnerships with 86 leading institutions globally.

CARVYKTI® reduces death risk by 45% in lenalidomide-refractory multiple myeloma patients, significantly extending overall survival in the CARTITUDE-4 study, presented at the 2024 International Myeloma Society Annual Meeting.

Dr. Naim Rashid received a $311,000 grant to develop an AI tool that recommends personalized clinical trials for pancreatic cancer patients, aiming to increase trial enrollment and reduce disparities.

Krishnan and Dhakal discuss MajesTEC-1 trial findings on teclistamab for relapsed/refractory multiple myeloma, highlighting efficacy (63% ORR, 46.1% CR) and safety concerns, including infections and AEs. They suggest future treatment shifts towards fixed-duration therapy and individualized dosing based on patient response.

Effective immediately, card charged prorated amount based on existing subscription level. Options: OK or Cancel.

MCW Cancer Center and CTSI use AI (OncoLLM) to automate patient-trial matching, improving clinical trial equity and patient care. The OncoLLM platform, developed with a focus on clinical data, outperforms existing AI models and matches medical professionals' accuracy, ensuring privacy and efficiency in the process. MCW's robust infrastructure and new Patient Navigation Program further support patient enrollment and participation in trials.